MENINGIOMASURVIVAL rateTREATMENT effectivenessBRAIN tumorsPROGNOSISSURGICAL excisionRADIOTHERAPYBackground: Meningiomas are extra-axial primary neoplasms that frequently arise from arachnoid cap cells. Meningiomas account for around 33% of all primary brain tumours. Objective: The aim of...
As exemplified in Figure 2 for tumour MBT-1, the malignant brain tumours of patients III-1(MBT-1), III-3 (MBT-3), and III-4 (MBT-4, MBT-4R) and the myoepithelioma of patient III-1 (My-1), but not his meningioma (M-1), showed loss of the wild-type G-allele and retention...
Objectives Socio-economic inequalities in survival have been reported for most adult cancers in England. The NHS Cancer Plan (2000) aimed to improve cancer... Ellis,L,Rachet,... - 《Journal of Epidemiology & Community Health》 被引量: 197发表: 2010年 Cancer survival in New Zealand: ethnic,...
Increases in postoperative survival are shown for sites dominated by histologically benign tumors, i.e., intracranial neurinoma, meningioma, and cancers of the endocrine glands such as parathyroid tumors. From 1970-1972 to 1980-1982 the 10-year relative survival rate (RSR) increased from 30% to...
Unusual clear cell, lymphoplasmacyte-rich, dural-based tumor with divergent differentiation: a tricky case mimicking a meningioma Summary We describe an unusual case of a recurrent dural neoplasm, previously diagnosed as meningioma. Histopathologically, the tumor is characterized by a... C Miracco,M...
Secondary endpoints included OS, objective response rate (ORR), duration of response (DOR), and prostate-specific antigen (PSA) response. For more information on the TALAPRO-2 trial (NCT03395197), go to www.clinicaltrials.gov. About TALZENNA ® (talazoparib) TALZENNA is an oral...
There was no significant change in the rate over the 15 year period either for all cancers or individual cancer types. Eighty six percent of registrations had central review of pathological material. There has been a significant move towards centralisation of care over the 15 years and a ...
CXCL11 protein was detected on tumour cells and tumour-associated vasculature in meningioma (Wurth et al, 2011), and CXCL11 mRNA or protein has been detected in a number of other solid tumours (Furuya et al, 2007; Lo et al, 2010; Monnier et al, 2011; Xia et al, 2011). If CXCL1...
The median survival time of all included patients was 16.0 months (0–155 months). The 1–, 3– and 5–year CSS rate was 62.66%, 35.76%, and 29.32%, respectively (Fig.2A). Meanwhile, the 1–, 3–and 5–year OS rate was 59.57%, 32.32% and 25.14%, respectively (Fig.2B). K-M...
GG = ganglioglioma and GNT = other glioneuronal tumors, PXA = pleomorphic xanthoastrocytoma and anaplastic pleomorphic xanthoastrocytoma; other = included further rare diagnoses like PNET, meningioma, ATRT, FCD, etc. A comprehensive list of abbreviations is provided in the Additio...